I think it's the fact that we have databases under development in the pharmaceutical area that give us the potential tool, if there is a desire to use them.
There is some potential from the databases that we have, and it's useful for people to know.... We don't want to duplicate databases; they're expensive to build. From our point of view, it's useful for people to understand what now exists, and if that is something that can be built on, added to, or in fact could be useful in some way to others, I think that would be helpful.